| P2093 | author name string | B I Posner | |
| | Q Chu | |
| | J F Yale | |
| | J Z Yu | |
| | A Shaver | |
| | C Vigeant | |
| | C Nardolillo | |
| P2860 | cites work | Electron paramagnetic resonance studies and insulin-like effects of vanadium in rat adipocytes | Q72910983 |
| | Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats | Q28579668 |
| | Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus | Q34183394 |
| | Effects of vanadyl derivatives on animal models of diabetes. | Q36300402 |
| | Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle | Q40511503 |
| | Stimulation of insulin-like growth factor II receptor binding and insulin receptor kinase activity in rat adipocytes. Effects of vanadate and H2O2. | Q41371828 |
| | Selectivity of the insulin-like actions of vanadate on glucose and protein metabolism in skeletal muscle | Q42100788 |
| | Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments | Q42475509 |
| | Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats | Q42510849 |
| | Oral administration of vanadate to streptozotocin-diabetic rats restores the glucose-induced activation of liver glycogen synthase | Q42793929 |
| | Insulinic actions of vanadate in diabetic rats | Q43684925 |
| | Antidiabetic Action of Vanadyl in Rats Independent of in Vivo Insulin-Receptor Kinase Activity | Q44273296 |
| | The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin-like effect on tyrosine phosphorylation | Q45205035 |
| | Insulinomimetic properties of trace elements and characterization of their in vivo mode of action | Q45252048 |
| | Vanadium treatment of diabetic Sprague-Dawley rats results in tissue vanadium accumulation and pro-oxidant effects | Q46694713 |
| | Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action | Q46730250 |
| | Effects of chronic vanadate administration in the STZ-induced diabetic rat. The antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding | Q48198781 |
| | Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats. | Q51618523 |
| | Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. | Q51618570 |
| | Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate. | Q54312575 |
| | In vivo insulin resistance in streptozotocin-diabetic rats--evidence for reversal following oral vanadate treatment. | Q54358800 |
| | Improvement of Glucose Homeostasis by Oral Vanadyl or Vanadate Treatment in Diabetic Rats is Accompanied by Negative Side Effects | Q57266636 |
| | Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used | Q57266641 |
| | Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions | Q59088311 |
| | Effects of vanadium on glucose metabolism | Q66974720 |
| | Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats | Q67278035 |
| | Insulinlike effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozocin-induced diabetic rats | Q67298013 |
| | The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s) | Q67897100 |
| | Insulin-like effects of vanadate in isolated rat adipocytes | Q68133840 |
| | Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats | Q68480145 |
| | Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulin | Q68504687 |
| | Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology | Q68627361 |
| | Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats | Q69099278 |
| | Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase | Q69267065 |
| | Oral vanadyl sulfate in treatment of diabetes mellitus in rats | Q69539256 |
| | Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment | Q69543992 |
| | Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase | Q69562489 |
| | Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats | Q69816672 |
| | Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats | Q70210893 |
| | Oral vanadate reduces Na(+)-dependent glucose transport in rat small intestine | Q70464204 |
| | Studies of vanadyl sulfate as a glucose-lowering agent in STZ-diabetic rats | Q72704149 |
| | Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics | Q72772936 |
| | The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from effects of vanadate as a (Na+-K+)ATPase inhibitor | Q72850009 |
| P433 | issue | 1-2 | |
| P304 | page(s) | 181-190 | |
| P577 | publication date | 1995-12-01 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | In vivo effects of peroxovanadium compounds in BB rats | |
| P478 | volume | 153 | |